This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 810 p38; 803341495
Reference
NICE. NICE recommends first ever treatment for children with rare muscle-wasting condition. Internet Document : 15 May 2019. Available from: URL: https://www.nice.org.uk/news/article/nice-recommends-first-ever-treatment-for-children-with-rare-muscle-wasting-condition
Rights and permissions
About this article
Cite this article
NICE recommends nusinersen for spinal muscular dystrophy. PharmacoEcon Outcomes News 829, 37 (2019). https://doi.org/10.1007/s40274-019-5951-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5951-1